| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nanocomposites | 6 | 2019 | 62 | 2.88 | Why? |
| Bandages | 3 | 2019 | 109 | 1.67 | Why? |
| Staphylococcus aureus | 7 | 2019 | 844 | 1.59 | Why? |
| Fibroins | 2 | 2018 | 10 | 1.51 | Why? |
| Chitin | 2 | 2018 | 32 | 1.45 | Why? |
| Titanium | 2 | 2019 | 175 | 1.29 | Why? |
| Cellulose | 3 | 2019 | 106 | 1.28 | Why? |
| Carcinogenesis | 2 | 2018 | 236 | 1.19 | Why? |
| Salvadoraceae | 2 | 2019 | 2 | 1.02 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2018 | 143 | 0.88 | Why? |
| Silver | 2 | 2019 | 327 | 0.86 | Why? |
| Anti-Infective Agents | 4 | 2019 | 1766 | 0.86 | Why? |
| Cheese | 2 | 2018 | 8 | 0.81 | Why? |
| Nanoparticles | 3 | 2019 | 2040 | 0.81 | Why? |
| Chemical Phenomena | 1 | 2019 | 22 | 0.80 | Why? |
| Candida albicans | 2 | 2018 | 217 | 0.80 | Why? |
| Sweat | 1 | 2020 | 127 | 0.79 | Why? |
| Alkalies | 1 | 2018 | 3 | 0.79 | Why? |
| Dental Pulp Cavity | 1 | 2018 | 16 | 0.78 | Why? |
| Acids | 1 | 2018 | 22 | 0.78 | Why? |
| Anti-Bacterial Agents | 9 | 2019 | 10083 | 0.74 | Why? |
| Aggressive Periodontitis | 1 | 2017 | 2 | 0.74 | Why? |
| Aggregatibacter actinomycetemcomitans | 1 | 2017 | 8 | 0.73 | Why? |
| Pasteurellaceae Infections | 1 | 2017 | 9 | 0.73 | Why? |
| Enterococcus faecalis | 1 | 2018 | 126 | 0.71 | Why? |
| Hypericum | 1 | 2017 | 29 | 0.70 | Why? |
| Peptide Nucleic Acids | 1 | 2017 | 28 | 0.70 | Why? |
| Antibiosis | 1 | 2017 | 26 | 0.69 | Why? |
| Genes, Bacterial | 1 | 2018 | 207 | 0.68 | Why? |
| Fusobacterium nucleatum | 1 | 2017 | 28 | 0.67 | Why? |
| Lactobacillus plantarum | 1 | 2017 | 30 | 0.67 | Why? |
| Escherichia coli | 5 | 2019 | 1547 | 0.67 | Why? |
| Materials Testing | 2 | 2019 | 380 | 0.66 | Why? |
| Neonatal Sepsis | 1 | 2017 | 69 | 0.65 | Why? |
| Carbapenems | 3 | 2018 | 343 | 0.65 | Why? |
| Acute-Phase Proteins | 1 | 2017 | 177 | 0.63 | Why? |
| Drug Carriers | 2 | 2019 | 590 | 0.62 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.61 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.59 | Why? |
| Virulence Factors | 1 | 2017 | 338 | 0.57 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2018 | 323 | 0.56 | Why? |
| Environmental Microbiology | 1 | 2020 | 575 | 0.56 | Why? |
| Bacterial Proteins | 5 | 2018 | 1318 | 0.55 | Why? |
| Aptamers, Nucleotide | 1 | 2017 | 265 | 0.53 | Why? |
| Metal Nanoparticles | 2 | 2018 | 771 | 0.53 | Why? |
| Gram-Negative Bacteria | 1 | 2018 | 473 | 0.52 | Why? |
| beta-Lactamases | 3 | 2018 | 759 | 0.51 | Why? |
| Plant Extracts | 3 | 2019 | 1514 | 0.51 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2018 | 398 | 0.50 | Why? |
| Bacteria | 4 | 2019 | 1897 | 0.49 | Why? |
| Probiotics | 2 | 2018 | 694 | 0.49 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.48 | Why? |
| Nanotechnology | 1 | 2019 | 821 | 0.48 | Why? |
| Culture Media | 2 | 2018 | 366 | 0.47 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.41 | Why? |
| Gluconacetobacter xylinus | 1 | 2018 | 1 | 0.39 | Why? |
| Molasses | 1 | 2018 | 1 | 0.39 | Why? |
| Whey | 1 | 2018 | 1 | 0.39 | Why? |
| Beta vulgaris | 1 | 2018 | 4 | 0.39 | Why? |
| Toxoplasmosis | 1 | 2019 | 59 | 0.39 | Why? |
| Disinfectants | 1 | 2020 | 1077 | 0.39 | Why? |
| PTEN Phosphohydrolase | 2 | 2019 | 70 | 0.38 | Why? |
| Temperature | 1 | 2019 | 2305 | 0.38 | Why? |
| Hypersensitivity | 1 | 2018 | 1137 | 0.36 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.35 | Why? |
| Microbial Sensitivity Tests | 7 | 2020 | 2886 | 0.34 | Why? |
| Spectroscopy, Fourier Transform Infrared | 4 | 2019 | 207 | 0.34 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2019 | 260 | 0.33 | Why? |
| Biocompatible Materials | 1 | 2019 | 214 | 0.32 | Why? |
| Chitosan | 1 | 2019 | 196 | 0.32 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.31 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.29 | Why? |
| Wound Healing | 1 | 2019 | 424 | 0.28 | Why? |
| Biomarkers | 3 | 2019 | 23361 | 0.28 | Why? |
| X-Ray Diffraction | 2 | 2019 | 249 | 0.27 | Why? |
| Iran | 8 | 2020 | 5467 | 0.27 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.26 | Why? |
| Autoimmune Diseases | 1 | 2017 | 1996 | 0.26 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.25 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.25 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.23 | Why? |
| Permeability | 2 | 2019 | 238 | 0.23 | Why? |
| Tuberculosis | 4 | 2020 | 2895 | 0.23 | Why? |
| MicroRNAs | 2 | 2019 | 1787 | 0.22 | Why? |
| Steam | 2 | 2019 | 132 | 0.22 | Why? |
| Cell Proliferation | 4 | 2019 | 1973 | 0.22 | Why? |
| Cerebrovascular Disorders | 1 | 2019 | 1040 | 0.21 | Why? |
| Elements | 1 | 2019 | 2 | 0.21 | Why? |
| Calixarenes | 1 | 2019 | 2 | 0.20 | Why? |
| Thermogravimetry | 1 | 2019 | 14 | 0.20 | Why? |
| Amylose | 1 | 2019 | 2 | 0.20 | Why? |
| Doxorubicin | 2 | 2019 | 313 | 0.20 | Why? |
| Faecalibacterium | 1 | 2019 | 16 | 0.20 | Why? |
| Satureja | 1 | 2019 | 5 | 0.20 | Why? |
| Carboxymethylcellulose Sodium | 1 | 2019 | 22 | 0.20 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.20 | Why? |
| Spectrophotometry, Ultraviolet | 1 | 2019 | 81 | 0.19 | Why? |
| Chromogenic Compounds | 1 | 2018 | 10 | 0.19 | Why? |
| Thiazolidinediones | 1 | 2019 | 70 | 0.19 | Why? |
| Food Packaging | 1 | 2019 | 27 | 0.19 | Why? |
| Enterobacter | 1 | 2018 | 18 | 0.19 | Why? |
| DNA Repair | 1 | 2019 | 114 | 0.19 | Why? |
| Cell Cycle Checkpoints | 1 | 2019 | 126 | 0.19 | Why? |
| Gene Transfer, Horizontal | 1 | 2018 | 64 | 0.19 | Why? |
| Leukemia, Myeloid | 1 | 2019 | 76 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.18 | Why? |
| Animals | 10 | 2021 | 78931 | 0.18 | Why? |
| Starch | 1 | 2018 | 21 | 0.18 | Why? |
| Anthracenes | 1 | 2017 | 28 | 0.18 | Why? |
| Gingiva | 1 | 2017 | 34 | 0.18 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.18 | Why? |
| Mycobacterium tuberculosis | 3 | 2020 | 1164 | 0.18 | Why? |
| Polyurethanes | 1 | 2018 | 37 | 0.18 | Why? |
| Histone Deacetylases | 1 | 2018 | 37 | 0.18 | Why? |
| Leishmania major | 1 | 2017 | 9 | 0.18 | Why? |
| Magnetite Nanoparticles | 1 | 2019 | 109 | 0.18 | Why? |
| bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.18 | Why? |
| Cell Line | 3 | 2018 | 12040 | 0.18 | Why? |
| Perylene | 1 | 2017 | 34 | 0.17 | Why? |
| Humans | 42 | 2021 | 930598 | 0.17 | Why? |
| Exotoxins | 1 | 2017 | 54 | 0.17 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.17 | Why? |
| Bone Resorption | 1 | 2017 | 61 | 0.17 | Why? |
| Oils, Volatile | 1 | 2019 | 127 | 0.17 | Why? |
| Nanofibers | 1 | 2019 | 143 | 0.17 | Why? |
| Staphylococcus epidermidis | 1 | 2017 | 53 | 0.17 | Why? |
| Lactobacillus | 1 | 2017 | 92 | 0.17 | Why? |
| Phenols | 1 | 2019 | 226 | 0.17 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2017 | 48 | 0.17 | Why? |
| DNA, Single-Stranded | 1 | 2017 | 95 | 0.16 | Why? |
| DNA Damage | 1 | 2019 | 285 | 0.16 | Why? |
| Caspase 3 | 1 | 2017 | 218 | 0.16 | Why? |
| Bacteriological Techniques | 1 | 2019 | 239 | 0.16 | Why? |
| Oligonucleotides | 1 | 2017 | 137 | 0.16 | Why? |
| Nontuberculous Mycobacteria | 1 | 2017 | 114 | 0.16 | Why? |
| Bacterial Toxins | 1 | 2017 | 185 | 0.15 | Why? |
| beta-Lactam Resistance | 1 | 2017 | 150 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2018 | 214 | 0.15 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.15 | Why? |
| Klebsiella pneumoniae | 2 | 2018 | 658 | 0.15 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.15 | Why? |
| Coronary Stenosis | 1 | 2019 | 273 | 0.15 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 167 | 0.14 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.14 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.14 | Why? |
| Vaccines, DNA | 1 | 2021 | 871 | 0.14 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.14 | Why? |
| Biofilms | 1 | 2017 | 304 | 0.14 | Why? |
| Copper | 1 | 2018 | 288 | 0.14 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.13 | Why? |
| Th17 Cells | 1 | 2019 | 657 | 0.13 | Why? |
| Ovarian Neoplasms | 1 | 2019 | 465 | 0.13 | Why? |
| Colorectal Neoplasms | 2 | 2018 | 1884 | 0.13 | Why? |
| Apoptosis | 3 | 2019 | 2335 | 0.13 | Why? |
| Polymers | 1 | 2018 | 507 | 0.13 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2019 | 698 | 0.12 | Why? |
| Humidity | 1 | 2019 | 944 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Data Accuracy | 1 | 2018 | 715 | 0.12 | Why? |
| Pseudomonas aeruginosa | 1 | 2017 | 652 | 0.12 | Why? |
| Neoplasms | 2 | 2020 | 17251 | 0.11 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.11 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.11 | Why? |
| Minisatellite Repeats | 1 | 2010 | 53 | 0.11 | Why? |
| Polysaccharides | 1 | 2019 | 854 | 0.11 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.11 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.10 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2010 | 116 | 0.10 | Why? |
| Mouth Neoplasms | 1 | 2017 | 463 | 0.10 | Why? |
| Toxoplasma | 1 | 2019 | 61 | 0.10 | Why? |
| Pancreatic Neoplasms | 1 | 2017 | 609 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.10 | Why? |
| Tensile Strength | 2 | 2019 | 42 | 0.10 | Why? |
| Antibodies, Protozoan | 1 | 2019 | 121 | 0.10 | Why? |
| Cell Survival | 2 | 2019 | 1581 | 0.10 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.10 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.10 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.09 | Why? |
| Software | 1 | 2020 | 2501 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Cell Adhesion | 1 | 2019 | 230 | 0.09 | Why? |
| Drug Resistance, Multiple | 2 | 2019 | 156 | 0.09 | Why? |
| Immune System | 1 | 2017 | 1479 | 0.09 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.09 | Why? |
| Hemostatics | 1 | 2019 | 142 | 0.09 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.08 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.08 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.08 | Why? |
| Waste Water | 1 | 2017 | 2185 | 0.08 | Why? |
| Dietary Supplements | 1 | 2019 | 2251 | 0.08 | Why? |
| Hemolysis | 1 | 2019 | 283 | 0.08 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.07 | Why? |
| Genetic Association Studies | 1 | 2019 | 559 | 0.07 | Why? |
| Viruses | 1 | 2018 | 2238 | 0.07 | Why? |
| Fibroblasts | 1 | 2019 | 839 | 0.07 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.07 | Why? |
| Crowding | 1 | 2020 | 731 | 0.07 | Why? |
| Luminescent Measurements | 1 | 2019 | 924 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Diabetes Complications | 2 | 2020 | 2358 | 0.07 | Why? |
| Kidney Failure, Chronic | 1 | 2019 | 3222 | 0.06 | Why? |
| Signal Transduction | 1 | 2019 | 7207 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2019 | 3633 | 0.05 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.05 | Why? |
| K562 Cells | 1 | 2019 | 91 | 0.05 | Why? |
| Dynamic Light Scattering | 1 | 2019 | 43 | 0.05 | Why? |
| Calorimetry, Differential Scanning | 1 | 2019 | 76 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| MCF-7 Cells | 1 | 2019 | 199 | 0.05 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.05 | Why? |
| Drug Liberation | 1 | 2019 | 141 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.05 | Why? |
| Plant Roots | 1 | 2019 | 108 | 0.05 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.05 | Why? |
| PPAR gamma | 1 | 2019 | 102 | 0.05 | Why? |
| Triglycerides | 1 | 2021 | 478 | 0.05 | Why? |
| Molecular Epidemiology | 2 | 2017 | 1638 | 0.05 | Why? |
| Lymphocyte Count | 2 | 2021 | 4758 | 0.04 | Why? |
| Chaperonin 60 | 1 | 2017 | 42 | 0.04 | Why? |
| Hospitals | 1 | 2017 | 11793 | 0.04 | Why? |
| Porins | 1 | 2017 | 45 | 0.04 | Why? |
| Isoenzymes | 1 | 2017 | 127 | 0.04 | Why? |
| Amikacin | 1 | 2017 | 62 | 0.04 | Why? |
| Unnecessary Procedures | 1 | 2019 | 175 | 0.04 | Why? |
| Cholesterol, LDL | 1 | 2021 | 499 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.04 | Why? |
| Clone Cells | 1 | 2017 | 312 | 0.04 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Hydrogen Bonding | 1 | 2019 | 599 | 0.04 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Endocytosis | 1 | 2019 | 451 | 0.04 | Why? |
| Drug Synergism | 1 | 2019 | 833 | 0.04 | Why? |
| Blood Coagulation | 1 | 2019 | 2768 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Drug Resistance, Neoplasm | 1 | 2019 | 447 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Methotrexate | 1 | 2019 | 471 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 13720 | 0.03 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2020 | 433 | 0.03 | Why? |
| Emigration and Immigration | 1 | 2020 | 501 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
| False Positive Reactions | 1 | 2019 | 1338 | 0.03 | Why? |
| Coronary Artery Disease | 1 | 2019 | 2570 | 0.03 | Why? |
| Genetic Predisposition to Disease | 1 | 2019 | 4027 | 0.03 | Why? |
| Particle Size | 1 | 2019 | 1052 | 0.03 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.03 | Why? |
| DNA | 1 | 2019 | 778 | 0.03 | Why? |
| Transcription Factors | 1 | 2019 | 784 | 0.03 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.03 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.03 | Why? |
| Antitubercular Agents | 1 | 2020 | 775 | 0.03 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.03 | Why? |
| Immunoglobulin M | 1 | 2019 | 9091 | 0.03 | Why? |
| Leukocytes | 1 | 2019 | 1046 | 0.03 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Child | 2 | 2017 | 70012 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.03 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.02 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2019 | 2115 | 0.02 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.02 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Endothelial Cells | 1 | 2019 | 2048 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Immunoglobulin G | 1 | 2019 | 21571 | 0.02 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2019 | 88759 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.00 | Why? |